• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/13/24 8:00:00 PM ET
    $AXON
    $ILMN
    $MRNA
    $MSTR
    Ordnance And Accessories
    Industrials
    Medical Specialities
    Health Care
    Get the next $AXON alert in real time by email

    NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NASDAQ:NDX), which will become effective prior to market open on Monday, December 23, 2024.

    The following three companies will be added to the Index: Palantir Technologies Inc. (NASDAQ:PLTR), MicroStrategy Incorporated (NASDAQ:MSTR), and Axon Enterprise, Inc. (NASDAQ:AXON).

    The Nasdaq-100 Index® is composed of 100 of the largest non-financial companies1 listed on The Nasdaq Stock Market® and dates to January 1985 – nearly 40 years ago –when it was launched along with the Nasdaq Financial-100™ Index, which is comprised of 100 of the largest financial stocks on Nasdaq® These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    The Nasdaq-100 Index® is the basis of the Invesco QQQ Trust (NASDAQ:QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index® performance. In addition, options, futures and structured products based on the Nasdaq-100 Index® and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following three companies will be removed from the Index: Illumina, Inc. (NASDAQ:ILMN), Super Micro Computer, Inc. (NASDAQ:SMCI), and Moderna, Inc. (NASDAQ:MRNA).

    Information

    For information about the three companies to be added to the Nasdaq-100 Index®, please visit the following respective company websites:

    Palantir Technologies Inc. – https://www.palantir.com/

    MicroStrategy Incorporated – https://www.microstrategy.com/

    Axon Enterprise, Inc. – https://www.axon.com/

    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    _______________

    1 As outlined in the Nasdaq-100 Index® Methodology

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X, or at www.nasdaq.com. 

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The Nasdaq OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG - 

    Media Relations Contact Investor Relations Contact 
    Name: Jennifer Lawson

    Email: Jennifer.Lawson@nasdaq.com

     Name: Index Client Services

    Email: indexservices@nasdaq.com

     
        


    Primary Logo

    Get the next $AXON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AXON
    $ILMN
    $MRNA
    $MSTR

    CompanyDatePrice TargetRatingAnalyst
    Strategy Inc
    $MSTR
    7/8/2026$130.00Overweight
    Barclays
    Axon Enterprise Inc.
    $AXON
    7/6/2026$600.00 → $750.00Buy
    Needham
    Palantir Technologies Inc.
    $PLTR
    7/2/2026$175.00Neutral → Buy
    DA Davidson
    Illumina Inc.
    $ILMN
    6/26/2026$185.00Mkt Perform
    Bernstein
    Palantir Technologies Inc.
    $PLTR
    6/16/2026Peer Perform
    Wolfe Research
    Super Micro Computer Inc.
    $SMCI
    6/11/2026Peer Perform
    Wolfe Research
    Illumina Inc.
    $ILMN
    6/10/2026$185.00Neutral → Overweight
    Analyst
    Illumina Inc.
    $ILMN
    5/15/2026$170.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $AXON
    $ILMN
    $MRNA
    $MSTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Strategy Inc with a new price target

    Barclays initiated coverage of Strategy Inc with a rating of Overweight and set a new price target of $130.00

    7/8/26 9:37:12 AM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    Needham reiterated coverage on Axon with a new price target

    Needham reiterated coverage of Axon with a rating of Buy and set a new price target of $750.00 from $600.00 previously

    7/6/26 7:49:44 AM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Palantir Technologies upgraded by DA Davidson with a new price target

    DA Davidson upgraded Palantir Technologies from Neutral to Buy and set a new price target of $175.00

    7/2/26 8:02:49 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Axon to Release Second Quarter 2026 Earnings on August 5, 2026

    SCOTTSDALE, Ariz., July 22, 2026 /PRNewswire/ -- Axon (NASDAQ:AXON), the global public safety technology leader, today announced that it will report second quarter 2026 financial results after the market closes on August 5, 2026. Axon will host a live Zoom video webinar to discuss the company's financial results at 5:00 p.m. ET that same day. The live webinar to discuss financial results, followed by Q&A, will be linked from Axon's investor relations website at https://investor.axon.com. An archived replay will be available after the call ends.Upcoming Conference ParticipationThe Company also announced that Axon will participat

    7/22/26 4:01:00 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Supermicro Provides Fourth Quarter of Fiscal Year 2026 Preliminary Business Update

    Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), an AI, Enterprise, Storage, and 5G/Edge IT Total Solution Provider, featuring Data Center Building Block Solutions® (DCBBS), today is providing a preliminary business update for the fourth quarter of fiscal year 2026 (Q4’26), ended June 30, 2026, and schedules earnings call for August 11th at 5pm EDT. Revenues for the fourth quarter of fiscal year 2026 are estimated to be near the low end of our guidance of $11.0 billion to $12.5 billion. GAAP and non-GAAP gross margins are estimated to be in the range of 15% to 17% which is significantly higher than our guidance of 8.2% to 8.4%, primarily due to a favorable cus

    7/21/26 4:05:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    NPM Announces Acquisition of Nasdaq Fund Secondaries (NFS)

    NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Nasdaq Private Market (NPM), a leading provider of liquidity, capital and investment solutions for private companies and their investors, today announced it has acquired NFS, Nasdaq, Inc.’s fund secondaries business. NPM is an independent company that spun out of Nasdaq in 2021. The acquisition expands NPM's secondary liquidity platform to encompass both direct company shares and multi-asset fund stakes - giving NPM the capabilities and scale to serve the full spectrum of private secondary liquidity demand from a single platform. "Liquidity is the defining challenge of today’s private markets, and secondaries have become the primary release valv

    7/21/26 8:44:30 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Investor Ab bought $4,882,116 worth of shares (56,782 units at $85.98) (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    6/15/26 4:30:19 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Director Torgeby Johan bought $958,320 worth of shares (12,000 units at $79.86), increasing direct ownership by 42% to 40,797 units (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/19/26 4:00:18 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Large owner Investor Ab bought $15,835,040 worth of shares (200,000 units at $79.18) (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/13/26 3:56:39 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $AXON
    $ILMN
    $MRNA
    $MSTR
    SEC Filings

    View All

    Super Micro Computer Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Super Micro Computer, Inc. (0001375365) (Filer)

    7/21/26 4:10:55 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    Axon Enterprise Inc. filed SEC Form 8-K: Leadership Update

    8-K - AXON ENTERPRISE, INC. (0001069183) (Filer)

    7/10/26 4:19:52 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Moderna Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Moderna, Inc. (0001682852) (Filer)

    7/8/26 7:08:16 AM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Moore Alexander D. sold $2,144,770 worth of shares (16,000 units at $134.05) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,095,095 units (SEC Form 4)

    4 - Palantir Technologies Inc. (0001321655) (Issuer)

    7/17/26 8:03:46 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    President Hoge Stephen exercised 53,336 shares at a strike of $19.15 and sold $3,605,514 worth of shares (53,336 units at $67.60) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Moderna, Inc. (0001682852) (Issuer)

    7/16/26 4:45:38 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Director Mcdonnell Michael R.

    4 - Moderna, Inc. (0001682852) (Issuer)

    7/10/26 5:08:03 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by MicroStrategy Incorporated

    SC 13G - MICROSTRATEGY Inc (0001050446) (Subject)

    11/14/24 6:24:12 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Leadership Updates

    Live Leadership Updates

    View All

    Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer

    New leaders bring extensive leadership experience across life sciences, diagnostics, and medical technologySAN DIEGO, July 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced the appointment of Mike Sullivan as Chief Commercial Officer, effective July 20, 2026, and Julie Coletti as Chief Legal Officer, effective August 3, 2026. The appointments add experienced leaders to Illumina's Executive Leadership Team as the company continues advancing its strategy, serving customers, driving growth, and delivering on its mission to improve human health around the world."We are excited to welcome Mike and Julie to Illumina," said Jacob Thaysen, chief executive officer of Illumina. "Mik

    7/9/26 9:05:00 AM ET
    $ILMN
    Medical Specialities
    Health Care

    Space Exploration Technologies Corporation to Join the Nasdaq-100 Index® Beginning July 7, 2026

    NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Space Exploration Technologies Corporation (NASDAQ:SPCX) will become a component of the Nasdaq-100 Index® prior to market open on Tuesday, July 7, 2026. For additional information, including notifications on changes to any Nasdaq Indexes, please go to https://indexes.nasdaq.com/ About Nasdaq Global Indexes Nasdaq Global Indexes is one of the world's leading index providers, offering a comprehensive suite of rules-based benchmarks and indexes. The Nasdaq-100 Index® — which measures the performance of 100 of the largest Nasdaq-listed non-financial companies — is tracked by more than 200 investment product

    6/26/26 8:00:00 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors

    Eli Lilly and Company's Chief Scientific and Product Officer brings pharmaceutical R&D and scientific leadership perspective to Illumina's BoardSAN DIEGO, June 23, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced the appointment of Daniel M. Skovronsky, MD, PhD, to its Board of Directors, effective June 16, 2026. Dr. Skovronsky brings extensive experience in drug discovery, clinical development and translational medicine, which are areas directly relevant to Illumina's work advancing genomics and multiomics platforms. "Dan brings a rare combination of scientific expertise, innovation leadership, and healthcare

    6/23/26 9:05:00 AM ET
    $ILMN
    Medical Specialities
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Financials

    Live finance-specific insights

    View All

    Axon to Release Second Quarter 2026 Earnings on August 5, 2026

    SCOTTSDALE, Ariz., July 22, 2026 /PRNewswire/ -- Axon (NASDAQ:AXON), the global public safety technology leader, today announced that it will report second quarter 2026 financial results after the market closes on August 5, 2026. Axon will host a live Zoom video webinar to discuss the company's financial results at 5:00 p.m. ET that same day. The live webinar to discuss financial results, followed by Q&A, will be linked from Axon's investor relations website at https://investor.axon.com. An archived replay will be available after the call ends.Upcoming Conference ParticipationThe Company also announced that Axon will participat

    7/22/26 4:01:00 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Supermicro Provides Fourth Quarter of Fiscal Year 2026 Preliminary Business Update

    Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), an AI, Enterprise, Storage, and 5G/Edge IT Total Solution Provider, featuring Data Center Building Block Solutions® (DCBBS), today is providing a preliminary business update for the fourth quarter of fiscal year 2026 (Q4’26), ended June 30, 2026, and schedules earnings call for August 11th at 5pm EDT. Revenues for the fourth quarter of fiscal year 2026 are estimated to be near the low end of our guidance of $11.0 billion to $12.5 billion. GAAP and non-GAAP gross margins are estimated to be in the range of 15% to 17% which is significantly higher than our guidance of 8.2% to 8.4%, primarily due to a favorable cus

    7/21/26 4:05:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    Palantir Announces Date of Second Quarter 2026 Earnings Release and Webcast

    Palantir Technologies Inc. (NASDAQ:PLTR) announced today that results for its second quarter ended June 30, 2026 will be released on Monday, August 3, 2026, following the close of U.S. markets. Palantir will host a webcast to discuss its results at 5:00 PM ET.A live webcast and replay will be available at investors.palantir.com, and participants can pre-register here. In addition, shareholders can submit and vote on questions by visiting https://app.saytechnologies.com/palantir-2026-q2.About Palantir Technologies Inc.Foundational software of tomorrow. Delivered today.Additional information is available at https://www.palantir.com.View source version on businesswire.com: https://www.businessw

    7/13/26 4:05:00 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology